| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |